Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …

Rationale: Exacerbations are key drivers of morbidity and mortality in chronic obstructive
pulmonary disease (COPD). Objectives: We compared the relative efficacy of the long-acting …

Study objectives To stratify COPD patients presenting with an acute exacerbation on the basis
of sputum color and to relate this to the isolation and viable numbers of bacteria recovered …

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity,
mortality, and resource use worldwide. The goal of this Official American Thoracic Society (…

… RA Stockley … Hill AT, Bayley D, Stockley RA. The interrelationship of sputum
inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med1999;160:893–8. …

PURPOSE: Viable bacteria are often isolated from airway secretions in clinically stable
patients with chronic bronchitis. We hypothesized that the number of organisms and bacterial …

… Stockley RA. Neutrophils and protease/antiprotease imbalance. … Burnett D., Chamba A.,
Hill SL, Stockley RANeutrophils from subjects with chronic obstructive lung disease show …

Chronic obstructive pulmonary disease (COPD) is characterised by an inflammatory
response by the lungs to inhaled substances such as cigarette smoking and air pollutants. In …

… It is tempting therefore to assume that TNF inhibition would be as beneficial in COPD as it
has been in other inflammatory conditions such as rheumatoid arthritis and Crohn's disease [23…

BACKGROUND Chronic obstructive pulmonary disease (COPD) is common although often
poorly characterised, particularly in primary care. However, application of guidelines to the …